PS Ratio
2.71
0.000.00%
Thu, 28 Nov 2024 00:59:53 GMT
Summary:
Xeris Biopharma Holdings price to sales ratio is currently 2.71, unchanged from the previous trading day. Over the past year, it has increased by +1.05 (+63.25%). XERS PS ratio is now -99.18% below its all-time high of 329.76.XERS PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% | +3.3% |
| 1 m1 month | +5.5% | +5.6% | +5.6% | - |
| 3 m3 months | +17.3% | +21.4% | +21.4% | - |
| 6 m6 months | +64.2% | +78.5% | +79.5% | - |
| ytdytd | +36.2% | +44.5% | +55.9% | - |
| 1 y1 year | +63.3% | +85.3% | +100.0% | +22.7% |
| 5 y5 years | -98.2% | -61.8% | +110.9% | +10000.0% |
XERS PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 2.78 | -2.5% | 2.31 | +17.3% |
| 3 m | 3 months | 2.78 | -2.5% | 2.07 | +30.9% |
| 6 m | 6 months | 2.78 | -2.5% | 1.64 | +65.2% |
| 1 y | 1 year | 2.78 | -2.5% | 1.48 | +83.1% |
| 3 y | 3 years | 9.09 | -70.2% | 1.30 | +108.5% |
| 5 y | 5 years | 150.25 | -98.2% | 1.30 | +108.5% |
| alltime | all time | 329.76 | -99.2% | 1.30 | +108.5% |
Xeris Biopharma Holdings PS Ratio History
| Date | Value |
|---|---|
| 2024 | 2.71(+36.2%) |
| 2023 | 1.99(+20.6%) |
| 2022 | 1.65(-77.6%) |
| Date | Value |
|---|---|
| 2021 | 7.38(-48.5%) |
| 2020 | 14.32(-79.7%) |
| 2019 | 70.49(-51.7%) |
| 2018 | 145.99 |
FAQ
- What is Xeris Biopharma Holdings price to sales ratio?
- What is the all time high PS ratio for Xeris Biopharma Holdings?
- What is XERS price to sales ratio year-to-date change?
- What is Xeris Biopharma Holdings PS ratio year-on-year change?
What is Xeris Biopharma Holdings price to sales ratio?
The current PS ratio of XERS is 2.71
What is the all time high PS ratio for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high price to sales ratio is 329.76
What is XERS price to sales ratio year-to-date change?
Xeris Biopharma Holdings price to sales ratio has changed by +0.72 (+36.18%) since the beginning of the year
What is Xeris Biopharma Holdings PS ratio year-on-year change?
Over the past year, XERS price to sales ratio has changed by +1.05 (+63.25%)